Efficacy and safety of twice-weekly and thrice-weekly dutasteride in men with androgenetic alopecia: A randomized, investigator-blind, active-controlled, parallel-group pilot study

Mendeley supplemental figures and table to accompany manuscript: Efficacy and safety of twice-weekly and thrice-weekly dutasteride in men with androgenetic alopecia: A randomized, investigator-blind, active-controlled, parallel-group pilot study.

随附于下述研究论文的孟德莱（Mendeley）补充图表与附表：《针对男性雄激素性脱发患者采用每周两次与每周三次度他雄胺治疗的疗效与安全性：一项随机、研究者设盲、阳性对照平行组预试验》